Levometadona Molteni

Levomethadone Hydrochloride, the active ingredient in Levometadona Molteni, is an opioid presented as an oral formulation for oral use. It is employed in the management of moderate to severe pain and as part of opioid dependence treatment programs, typically in adult patients requiring controlled analgesia or substitution therapy.

GNH USA supplies Levometadona Molteni as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Levomethadone Hydrochloride is used in opioid‑related pathways for analgesia and dependence management.

- Chronic pain: provides sustained opioid analgesia for patients with moderate to severe persistent pain. - Post‑surgical pain: offers effective short‑term relief after major surgical procedures. - Opioid dependence: facilitates opioid substitution therapy to reduce withdrawal symptoms and support recovery.

Levomethadone Hydrochloride may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Constipation: reduced bowel movements. - Drowsiness: increased sleepiness or fatigue. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - QT interval prolongation: cardiac rhythm disturbance. - Severe hypotension: marked drop in blood pressure.

When prescribing Levomethadone Hydrochloride, clinicians should observe several precautionary measures to ensure patient safety.

- Assess respiratory function: evaluate baseline breathing and avoid use in severe respiratory compromise. - Review cardiac history: monitor QT interval in patients with known cardiac arrhythmias. - Evaluate liver function: dose may require adjustment in hepatic impairment. - Avoid concurrent CNS depressants: limit use with benzodiazepines or alcohol to reduce sedation risk. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Levomethadone Hydrochloride can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Other opioids: additive respiratory depression and sedation. - QT‑prolonging agents (e.g., certain antiarrhythmics, macrolide antibiotics): increased risk of cardiac arrhythmias. - CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may raise levomethadone plasma levels.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, barbiturates, alcohol): enhanced sedation. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce drug concentration. - Antidepressants (e.g., SSRIs, SNRIs): potential for serotonin syndrome, monitor closely.